8-K: Hillenbrand Reports Fiscal Second Quarter 2025 Results: Revenue Declines Amid Macroeconomic Uncertainty
Earnings Release
Hillenbrand's Q2 2025 revenue decreased by 9% year-over-year to $716 million, impacted by lower volume in the Advanced Process Solutions (APS) segment and macroeconomic headwinds.
Summary
- Hillenbrand reported a 9% decrease in revenue for the second quarter of fiscal year 2025, reaching $716 million.
- The decline is primarily attributed to lower volume in the Advanced Process Solutions (APS) segment.
- GAAP EPS decreased to $(0.58) from $0.09 in the prior year, mainly due to a loss on the sale of a majority stake in the Milacron injection molding and extrusion business.
- Adjusted EPS decreased by 21% to $0.60, driven by lower APS volume.
- The company completed the sale of a majority stake in the Milacron business on March 31st, receiving net proceeds of approximately $265 million, which were used to reduce debt.
- Hillenbrand is updating its fiscal year 2025 guidance to reflect the impact of tariffs and increased macroeconomic uncertainty, with EPS now expected to be in the range of $2.10 to $2.45.
- Q3 adjusted EPS is projected to be between $0.46 and $0.53.
- The company also entered into an agreement to sell TerraSource Global for $245 million, expecting after-tax cash proceeds of approximately $100 million.
- Net debt as of March 31, 2025, was $1.46 billion, with a net debt to pro forma adjusted EBITDA ratio of 3.4x.
- Liquidity stood at approximately $770 million, including $458 million in cash on hand.
Sentiment
Score: 5
Explanation: The sentiment is neutral to slightly negative. While the company is taking steps to mitigate challenges and focusing on growth areas, the current results and updated guidance reflect a challenging environment. The divestitures are positive, but the overall financial performance is weaker than the previous year.
Positives
- The sale of the Milacron business generated significant proceeds used to reduce debt.
- The company is focusing on higher-margin, higher-growth, and less cyclical businesses.
- Solid year-over-year order growth was experienced in the food, health, and nutrition portfolio, as well as separation products.
- The sale of TerraSource Global will further reduce debt and improve net leverage.
- Liquidity remains strong at approximately $770 million.
Negatives
- Revenue decreased by 9% year-over-year.
- GAAP EPS decreased significantly to $(0.58).
- Adjusted EPS decreased by 21%.
- The company is facing increased macroeconomic uncertainty and the impact of tariffs.
- Backlog of $1.59 billion decreased 15% compared to the prior year primarily due to lower order intake.
Risks
- Global market and economic conditions, including volatility in financial markets and the impact of tariffs, pose a risk.
- Business disruptions related to IT, cyber-attacks, or catastrophic losses could affect performance.
- Increasing competition for skilled workers and labor shortages are potential challenges.
- Uncertainty related to environmental regulation and climate change presents risks.
- Increased costs, poor quality, or unavailability of raw materials could impact profitability.
- Negative effects of acquisitions, including the Schenck Process FPM business and Linxis Group SAS acquisitions, on the company's business, financial condition, results of operations and financial performance.
Future Outlook
Hillenbrand is updating its fiscal year 2025 guidance to reflect the impact of tariffs and increased macroeconomic uncertainty, with EPS now expected to be in the range of $2.10 to $2.45. Q3 adjusted EPS is projected to be between $0.46 and $0.53.
Management Comments
- Kim Ryan, President and Chief Executive Officer of Hillenbrand, stated that she was pleased with the business performance despite worsening global macroeconomic conditions.
- Ryan noted that the company experienced solid year-over-year order growth in its food, health, and nutrition portfolio, as well as separation products.
- Ryan mentioned that the company expects customers to remain cautious in their capital investment decisions due to increased tariffs and heightened macro uncertainty.
- Ryan stated that the company remains confident in the long-term growth prospects of its end markets and the strong competitive positioning of its industry-leading brands.
- Ryan believes that the company's portfolio transformation positions it to drive profitable growth once macro conditions improve.
Industry Context
The announcement reflects the challenges faced by industrial companies due to global macroeconomic uncertainty and tariffs. The company's focus on higher-growth markets and cost mitigation strategies aligns with industry trends to navigate these challenges.
Comparison to Industry Standards
- Compared to peers like Illinois Tool Works (ITW) and Dover Corporation (DOV), Hillenbrand's revenue decline is more pronounced, reflecting specific challenges in its APS segment.
- While ITW and Dover have diversified portfolios that help mitigate cyclical downturns, Hillenbrand's reliance on specific end markets makes it more susceptible to macroeconomic headwinds.
- The adjusted EBITDA margin of 17.0% 17.5% for the full year is lower than the typical margins seen in companies like ITW, which often exceed 20%.
- The net debt to pro forma adjusted EBITDA ratio of 3.4x is higher than some of its peers, indicating a higher leverage level.
- The divestiture of the Milacron business is a strategic move similar to actions taken by other industrial conglomerates to streamline their portfolios and focus on core competencies.
Stakeholder Impact
- Shareholders will be impacted by the decreased earnings and updated guidance.
- Employees may be affected by restructuring and cost-cutting measures.
- Customers may experience caution in capital investment decisions due to macroeconomic uncertainty.
- Suppliers may face pressure to reduce costs and adapt to supply chain changes.
- Creditors will be monitoring the company's debt levels and deleveraging efforts.
Next Steps
- The company will hold a conference call on April 30, 2025, to discuss the earnings results.
- The company expects to close the sale of TerraSource Global in late fiscal third quarter or early fiscal fourth quarter 2025.
- The company will continue to execute strategies to strengthen its supply chain and mitigate increased costs.
Key Dates
| Date | Description |
|---|---|
| March 31, 2025 | End of fiscal second quarter and completion of the sale of a majority stake in the Milacron injection molding and extrusion business. |
| April 29, 2025 | Date of the earnings announcement and the definitive agreement to sell TerraSource Global. |
| April 30, 2025 | Scheduled conference call and webcast to discuss the earnings results. |
| Late fiscal third quarter or early fiscal fourth quarter 2025 | Expected closing of the TerraSource Global transaction. |
| May 15, 2025 | Replay of the conference call available until this date. |
| May 30, 2025 | Webcast archived through this date. |
Keywords
Hillenbrand, revenue, EPS, Milacron, TerraSource, tariffs, macroeconomic uncertainty, Advanced Process Solutions, Molding Technology Solutions, divestiture, debt reduction, guidance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.